glp 1 and kidney function Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus chronic disease: an approach for the nephrologist Glucagon-like peptide-1 receptor signaling modifies
Description
The bottom line: diagnosis matters
& Wei, W
Many patients dont realize these medications are FDA-approved for preventing heart disease
The cost-effectiveness calculation becomes complex when considering efficacy differences
Cardiovascular Risks While some GLP-1 drugs improve heart health, patients with existing heart conditions require close monitoring
As demand grows, so does the cost to employer-sponsored health plans
